It was previously shown that ligand‐dependent PlexinB2 activity elicits ErbB2 tyrosine phosphorylation and oncogenic signaling in breast cancer cells (Gurrapu et al, 2018). This evidence concerns the gene ERBB2 and breast carcinoma.